Team Digital BBC

january-2025-federal-reserve-survey-mixed-trends-in-bank-lending-practices

January 2025 Federal Reserve Survey Mixed Trends in Bank Lending Practices

According to the Federal Reserve’s January 2025 Senior Loan Officer Opinion Survey, business loan standards are tightening, household loan standards are unchanged, commercial and industrial loan demand is rising, and residential real estate loan demand is weakening. January 2025 Federal Reserve Survey Mixed Trends in Bank Lending Practices The Federal Reserve’s January 2025 Senior Loan…

Read More
alaskas-cruise-boom-a-boon-for-business-but-at-what-cost-to-the-environment

Alaska’s Cruise Boom: A Boon for Business, But at What Cost to the Environment?

Millions of visitors visit Alaska each year to see its breathtaking landscapes and thriving wildlife, with cruise tourism at the heart of the state’s economy. In Ketchikan, a town of just 8,000 people, daily cruise visitors can swell the population to over 17,000, transforming quiet streets into bustling tourist hotspots. To business owners like Lincon…

Read More
cdc-removes-key-health-data-following-trump-executive-orders-sparking-concerns

CDC Removes Key Health Data Following Trump Executive Orders, Sparking Concerns

In a move that has alarmed public health experts and advocacy groups, the Centers for Disease Control and Prevention (CDC) has taken down several websites and datasets related to HIV, LGBTQ health, and youth behavior. The removal comes in compliance with executive orders from President Donald Trump, which direct federal agencies to eliminate diversity, equity,…

Read More
new-non-opioid-painkiller-brings-hope-but-cost-and-coverage-raise-questions

New Non-Opioid Painkiller Brings Hope, But Cost and Coverage Raise Questions

The groundbreaking non-opioid painkiller has recently been launched on the market. It holds much promise for patients seeking relief without risking their lives due to the potential of traditional pain medications. Although preliminary results have been encouraging, experts warn that accessibility could be challenging. The drug, developed by Vertex Pharmaceuticals, showed expected levels of pain…

Read More